Effects of Tagatose on Glycemic Response and Gastrointestinal Microbiota in Healthy Adults

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
The primary objective of this clinical-trial is to determine, in subjects with impaired fasting glucose (IFG) and/or insulin resistance (IR), if tagatose meets the definition of a prebiotic, namely that consuming tagatose for 4 weeks selectively stimulates the selective growth of bacteria in the colon and is associated with a health benefit (oral glucose tolerance) when compared to consuming the control treatment (10g sucrose) for 4 weeks.
Epistemonikos ID: 0e976b72f5934ace1d06d4aea8e69174d9d6ab3f
First added on: Apr 11, 2025